Ryszard Kole
Keine laufenden Positionen mehr
Karriereverlauf von Ryszard Kole
Ehemalige bekannte Positionen von Ryszard Kole
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Ercole Biotech, Inc.
 Ercole Biotech, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Sarepta Therapeutics, Inc., Ercole Biotech, Inc. develops splice switching drugs for the treatment of major human diseases. The company is based in Research Triangle Park, NC. The company was founded by Jorn Gorlach. Ercole Biotech was acquired by Sarepta Therapeutics, Inc. on March 20, 2008 for $8.25 million. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2001 | - |
| Präsident | 01.01.2001 | - | |
| The University of North Carolina at Charlotte | Corporate Officer/Principal | - | - |
| SAREPTA THERAPEUTICS, INC. | Corporate Officer/Principal | 10.04.2008 | - |
Ausbildung von Ryszard Kole
| Polish Academy of Sciences | Doctorate Degree |
Statistik
International
| Vereinigte Staaten | 4 |
| Polen | 2 |
Operativ
| Corporate Officer/Principal | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
| President | 1 |
Sektoral
| Consumer Services | 3 |
| Health Technology | 2 |
| Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| SAREPTA THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Ercole Biotech, Inc.
Ercole Biotech, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Sarepta Therapeutics, Inc., Ercole Biotech, Inc. develops splice switching drugs for the treatment of major human diseases. The company is based in Research Triangle Park, NC. The company was founded by Jorn Gorlach. Ercole Biotech was acquired by Sarepta Therapeutics, Inc. on March 20, 2008 for $8.25 million. | Commercial Services |
- Börse
- Insiders
- Ryszard Kole
- Erfahrung
